Resource Center

Nov 17, 2020
  |  Video

Relevance of Physiologically Based Biopharmaceutical Modeling (PBBM) in the Approval of Generic Products

The Webinar “Relevance of Physiologically Based Biopharmaceutical Modeling (PBBM) in the Approval of Generic Products”, which will be presented in Spanish by Dr. Sandra Suárez-Sharp, Vice President – Regulatory Affairs at Simulations Plus, Inc.

This program is a joint effort between RedIF and Simulations Plus, Inc

Contact Us About This Video